NVCT
Nuvectis Pharma Inc
22.00$
-0.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.6% | 87.6% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.3% | 86.3% | 98.0% | 99.7% | 99.6% | 99.8% | |
| 86.3% | 86.3% | 98.0% | 99.7% | 99.6% | 99.8% | |
| 0.2% | 265.4% | 30.3% | 36.4% | 47.8% | 41.9% | |
| 0.2% | 36.3% | 30.3% | 36.4% | 47.8% | 41.9% | |
| 0.2% | 15.9% | 14.3% | 14.4% | 13.4% | 19.8% | |
| -0.2% | -165.4% | 69.7% | 63.6% | 52.2% | 58.1% | |
| -0.2% | -193.8% | -156.8% | -282.7% | -393.6% | -314.4% | |
| 191.0% | 191.0% | 62.0% | 81.1% | 92.0% | 68.8% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.